annual report 2003 year ended march 31 strategic focus on human health continually providing the superior medicines essential to people s financial highlights 1 our stakeholders 2 6 research development and pipeline 8 marketing 11 management discussion analysis of operations 13 pharmaceuticals related businesses manufacturing 16 environmental protection social responsibility 17 condition 18 consolidated statements 22 board directors corporate auditors 35 subsidiaries affiliates directory 36 data 37 since 1957 shionogi group has followed a mission today we remain committed creating that effectively improve healthcare raise quality life for around world takes an integrated approach drug creation production promote effectiveness in improving earn trust professionals patients this is company ability continue growing expanding its globally meet expectations including customers society shareholders employees profile contents forward looking
